A marathon, 100 kilometers (62 miles) or even 230 kilometers (143 miles) in a single effort: Anyone running such distances puts enormous strain on their body. At the same time, levels of the body's own cannabis-like signaling molecules rise significantly. Dr. Michael Siebers from the Institute of Forensic Psychiatry and Sex Research at the University of Duisburg-Essen and his team have, for the first time, tracked in greater detail how these so-called endocannabinoids develop over the course of an entire marathon and during extreme ultramarathon distances. The study has been published in BMC Medicine.
Runner's High: Study Links Extreme Distances to Increased Cannabis-like Molecules
A study led by Dr. Michael Siebers from the University of Duisburg-Essen reveals that extreme running distances significantly increase the body's cannabis-like signaling molecules. This research, published in BMC Medicine, provides insights into the physiological effects of long-distance running. Understanding such studies can contribute to discussions on health and wellness in Iran, especially in the context of sports and physical fitness.
👥 Key Players
📰 What Happened
A study has shown that extreme running distances lead to significant increases in the body's cannabis-like molecules, known as endocannabinoids. This research highlights the physiological changes that occur during long-distance running.
- The study tracked endocannabinoid levels during marathons and ultramarathons.
- It was published in BMC Medicine, indicating peer-reviewed credibility.
💡 Why It Matters
📚 Background
Endocannabinoids are naturally occurring compounds in the body that can affect mood and pain perception. This study provides insights into how extreme physical activity can influence these compounds.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%